TW202421104A - 異雙官能化合物及治療疾病之方法 - Google Patents

異雙官能化合物及治療疾病之方法 Download PDF

Info

Publication number
TW202421104A
TW202421104A TW112134290A TW112134290A TW202421104A TW 202421104 A TW202421104 A TW 202421104A TW 112134290 A TW112134290 A TW 112134290A TW 112134290 A TW112134290 A TW 112134290A TW 202421104 A TW202421104 A TW 202421104A
Authority
TW
Taiwan
Prior art keywords
methods
treating disease
heterobifunctional compounds
compounds
heterobifunctional
Prior art date
Application number
TW112134290A
Other languages
English (en)
Inventor
凱爾 J 伊斯曼
布里克 凱瑟琳 Ｊ 凱瑟
詹姆斯 約翰 穆索
馬修 亞歷山大 佩里
大衛 Ｅ 普里歐
卡納克 沙伊爾 雷納
尼萊斯 Ｋ 扎瓦
塔維 內克利沙
塞繆爾 Ｗ 格里茨
托德 博薩納克
Original Assignee
美商海爾達醫療運營公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商海爾達醫療運營公司 filed Critical 美商海爾達醫療運營公司
Publication of TW202421104A publication Critical patent/TW202421104A/zh

Links

Abstract

本發明提供異雙官能化合物、醫藥組合物及其在治療諸如癌症等疾病中之用途。
TW112134290A 2022-09-08 2023-09-08 異雙官能化合物及治療疾病之方法 TW202421104A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/404,569 2022-09-08
US63/494,406 2023-04-05

Publications (1)

Publication Number Publication Date
TW202421104A true TW202421104A (zh) 2024-06-01

Family

ID=

Similar Documents

Publication Publication Date Title
MX2021009246A (es) Inmunomoduladores, composiciones y metodos de los mismos.
MX2022015272A (es) Inhibidores de la proteina kras g12c y usos de estos.
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
EP3934652A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES
MX2023002507A (es) Inhibidores de cd73.
WO2004052280A3 (en) Anti-angiogenic compounds and their use in cancer treatment
TW200628473A (en) Novel heterocycles
NZ788133A (en) Cd73 inhibitors
ZA202211667B (en) Multispecific heavy chain antibodies with modified heavy chain constant regions
CR20230149A (es) Anticuerpos de cadena pesada multiespecíficos con regiones constantes de cadena pesada modificadas (divisional exp no 2022-539)
MX2023001997A (es) Compuestos biciclicos, composiciones y usos de los mismos.
MX2021012769A (es) Anticuerpos bloqueadores cd73.
MX2020012107A (es) Composiciones y procedimientos para el tratamiento del cancer.
MX2010003269A (es) Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa.
WO2021207433A3 (en) Epitopes of sars-cov-2 neutralizing antibodies
MX2022001841A (es) Anticuerpos contra ilt2 y uso de los mismos.
ZA202006071B (en) Antiproliferation compounds and uses thereof
MX2020012281A (es) Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiacepinona y metodos de uso de las mismas.
MX2023010711A (es) Fenalquilaminas y métodos de preparación y uso de las mismas.
WO2020231739A3 (en) Compounds and methods for treating cancer
MX2022015966A (es) Anticuerpos y metodos para tratar enfermedades asociadas a claudina.
WO2022034524A3 (en) Antibodies against ilt2 and use thereof
WO2005081972A3 (en) Maleiimide anti-tumor phosphatase inhibitors
TW202421104A (zh) 異雙官能化合物及治療疾病之方法
TW202423930A (zh) 異雙官能化合物及治療疾病之方法